Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://finance.yahoo.com/news/axsome-therapeutics-announces-fda-approval-104500101.html
0
0
Axsome Therapeutics Announces FDA Approval of AUVELITY™, the First and Only Oral NMDA Receptor Antagonist for the Treatment of Major Depressive Disorder in Adults - Yahoo Finance
+ 34 more
8/19/22 at 10:45am
Organization
Yahoo Entertainment
Authors
Axsome Therapeutics
Inc.
Details
48 words
Summarize
Drugs & Medications
Business & Industrial
Depression
Yahoo Finance AUVELITY
Axsome Therapeutics Announces FDA Approval
AUVELITYTM
labeling
NMDA Receptor Antagonist for the Treatment of Major Depressive Disorder
AUVELITY is the first and only rapid-acting oral treatment approved with labeling of statistically significant improvement in depressive symptoms compared to...
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...